NCT02695173View on ClinicalTrials.gov

Complications of UTI in Patients on Dapagliflozin

CompletedOBSERVATIONAL
Enrollment

683,380

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 1, 2020

Study Completion Date

November 30, 2020

Conditions
Severe Complications of Urinary Tract Infections
Trial Locations (3)

Unknown

Research Site, Wilmington

Research Site, Washington D.C.

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY